2011 Anniversary Yearbook - EUFEPS today and history

More documents

Recommendations

Info

2. PRESIDENT’S INTRODUCTION Democratically, moderated organisations that seek to serve member societies for the benefit of science must be an engine of change for good in Europe. We live in a constantly changing world and as age demographics change, the burden of health care becomes more pressing. The faster development of effective and safe medicines for all has been the watchword of EUFEPS since the beginning, and the efforts of previous generations of scientists associated with our twenty-year old organisation have achieved much in the path towards this goal. Europe is periodically beset by upheavals, in part mirroring changes elsewhere in the world, especially America. Changes in legislation for cheaper medicines have a knock-on effect on our industry and the nature of the pharmaceutical market changes. Processes requiring expensive raw material and low-cost labour move steadily east, leaving Europe to contemplate the nature of its pharmaceutical sciences. There is no doubt that we will be faced with the challenges of innovation in medicines, which extends through advanced products, through systems of monitoring health, personalised medicines, concern for our environment and the adoption of science-led regulation. This generates a need for better education and training and communication and a more intellectually nimble workforce, able to adapt to new demands in the industry. Our academic institutions must reflect these changes and be more cognisant of the changing requirements and skill sets needed and avoid complacency. At any time in history, a seed change is either with us or just around the corner and EUFEPS exists to help its member organisations to realise new goals though interactions such as PharmSciFair and specialist distillation of information in networks. The future of EUFEPS depends on the enthusiasm of its membership. As a not-for-profit organisation, contributing to EUFEPS does not bring personal financial riches, but it does provide satisfaction that we are helping the next generations through mentorship and discussion. Being part of this august and worthy organisation is exhausting but fun and it is so easy to get deeply involved. I urge you to do so and promise that the deep satisfaction you will gain in making new connections and discovering science directions will amply offset the commitment of time. With best wishes, Clive G Wilson F.A.P.S., F.C.R.S. President European Federation of Pharmaceutical Sciences – EUFEPS 10
3. Mission, membership and operational platforms The mission of the European Federation for Pharmaceutical Sciences (EUFEPS) is to serve and advance excellence in the pharmaceutical sciences and innovative drug research in Europe, including in training and education, and to represent the interests of scientists engaged in drug research and development, drug regulation, drug utilisation, and drug policy making. Member Societies, Member Institutions and Individual Members are EUFEPS membership categories. EUFEPS is the only pan-European body to represent the interests of scientists in industry, academia, government and other institutions engaged in drug research, development, regulation and policymaking through Europe. It is an organisation for and run by scientists, forming a wide-range network and actively contributing to the ideals of the European pharmaceutical scientific community. The recruitment of younger generations of pharmaceutical scientists for EUFEPS activities is another prime goal. As regional organisation EUFEPS is bridging between the national and the global levels. To achieve its objectives EUFEPS initiates and runs European projects and networks. It organises, co-organises and co-sponsors congresses, conferences, workshops and courses on specialised or general themes, including many sessions in the Pharmaceutical Sciences Fair and Exhibition (PharmSciFair). The European Journal of Pharmaceutical Sciences is the Official Scientific Journal of EUFEPS. Operational platforms of EUFEPS: �� Membership �� Networks �� Senate �� Research and Policy Collaboration �� The PharmSciFair �� Meetings and Events �� Education and Training �� Communication �� Finance and Funding �� President’s Conference �� Council and Open Forum �� Executive Committee �� Central Office 11
Page 1 and 2: EUFEPS Yearbook 2011 20 th Annivers
Page 3 and 4: cal Sciences 2001 2002 2003 2004 20
Page 6 and 7: Pharma Ingredients & Services Custo
Page 8 and 9: The Gamlen Tablet Press The world
Page 10 and 11: Sustainable sponsorship of EUFEPS g
Page 14 and 15: 4. Member Societies Academy of Phar
Page 16 and 17: Croatian Pharmaceutical Society - C
Page 18 and 19: Hellenic Society of Medicinal Chemi
Page 20 and 21: Norwegian Pharmaceutical Society No
Page 22 and 23: Romanian Society of Pharmaceutical
Page 24 and 25: Swedish Swedish Academy Academy of
Page 26 and 27: 5. Individual Memberships Represent
Page 28 and 29: B. The membership terminates: • i
Page 30 and 31: K. The Executive Director shall •
Page 32 and 33: 7. Executive Committee 2010-2011 EU
Page 34 and 35: 8. Advisory Committees Committee on
Page 36 and 37: 9. EUFEPS Networks Scope and aim Th
Page 38 and 39: Network Environment and Pharmaceuti
Page 40 and 41: 10. Awards and Prizes EUFEPS is, si
Page 42 and 43: The New Safe Medicines Faster Award
Page 44 and 45: 12. The Pharmaceutical Sciences Fai
Page 46 and 47: 14. EUFEPS in EU Projects Since est
Page 48 and 49: 16. EUFEPS on the Global Scene Sinc
Page 50 and 51: 17. Sponsorship Recognition The cor
Page 52 and 53: Selection of articles from the EUFE
Page 54 and 55: EUFEPS Newsletter, 1992, vol. 1, is
Page 62 and 63:
EUFEPS Newsletter, 1994, vol. 3, is
Page 64 and 65:
Frankfurt. CIR consists of a core g
Page 66 and 67:
Objective 5 To enhance the recognit
Page 68 and 69:
that they have reached the conclusi
Page 70 and 71:
The procedure is safe and of relati
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
EUFEPS Newsletter, 2001, vol. 10, i
Page 80 and 81:
XXVIII
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
paradigm shift regarding the qualit
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
professionals into academia, indust
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
ecomes an issue’ in Verona (2006)
Page 112 and 113:
on which “Theology, Jurisprudence
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
important steps towards a comprehen
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
and set up their “own” programm
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
show all

2011 Anniversary Yearbook - EUFEPS today and history

Create successful ePaper yourself

Delete template?

Save as template?